CIK 0000877860
- Large accelerated filer
NATIONAL HEALTH INVESTORS INC
Sign in to watch- Ticker
- NHI
- Exchange
- NYSE
- Industry
- Real Estate Investment Trusts
- FY end
- Dec 31
- Incorporated
- MD
- Entity type
- Operating
- EIN
- 621470956
- Phone
- +1 615-890-9100
- Business address
- 222 ROBERT ROSE DRIVE, MURFREESBORO, TN, 37129
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-15 | Mendelsohn D. Eric CEO and President | Option exercise | +13,334 | $54.73 | $730K | 234,467 |
| 2026-01-15 | Mendelsohn D. Eric CEO and President | Option exercise | +13,333 | $57.76 | $770K | 247,800 |
| 2026-01-15 | Mendelsohn D. Eric CEO and President | Shares withheld for taxes | −135,295 | $79.23 | $10.7M | 112,505 |
| 2026-01-15 | Mendelsohn D. Eric CEO and President | Option exercise · Stock Options (Right to Buy) 2-25-2021 | −41,666 | 0 | ||
| 2026-01-15 | Mendelsohn D. Eric CEO and President | Option exercise · Stock Options (Right to Buy) 2-25-2021 | −41,666 | 0 | ||
| 2026-01-15 | Mendelsohn D. Eric CEO and President | Option exercise · Stock Options (Right to Buy) 2-25-2021 | −41,668 | 0 | ||
| 2026-01-15 | Mendelsohn D. Eric CEO and President | Option exercise · Stock Option (Right to Buy) 2023 | −13,334 | 0 | ||
| 2026-01-15 | Mendelsohn D. Eric CEO and President | Option exercise · Stock Option (Right to Buy) 2024 | −13,333 | 0 | ||
| 2026-01-14 | MCCABE ROBERT A JR Director | Option exercise | +25,000 | $69.20 | $1.7M | 60,274.17 |
| 2026-01-14 | MCCABE ROBERT A JR Director | Shares withheld for taxes | −21,836 | $79.23 | $1.7M | 38,438.17 |
| 2026-01-14 | MCCABE ROBERT A JR Director | Option exercise · Stock Options (Right to Buy) 2-25-2021 | −25,000 | 0 | ||
| 2025-12-09 | SWAFFORD CHARLOTTE A Director | Option exercise | +25,000 | $69.20 | $1.7M | 135,185 |
| 2025-12-09 | SWAFFORD CHARLOTTE A Director | Option exercise | +25,000 | $53.41 | $1.3M | 160,185 |
| 2025-12-09 | SWAFFORD CHARLOTTE A Director | Option exercise | +10,000 | $54.73 | $547K | 170,185 |
| 2025-12-09 | SWAFFORD CHARLOTTE A Director | Option exercise | +10,000 | $57.76 | $578K | 180,185 |
| 2025-12-09 | SWAFFORD CHARLOTTE A Director | Option exercise | +10,000 | $73.34 | $733K | 190,185 |
| 2025-12-09 | SWAFFORD CHARLOTTE A Director | Shares withheld for taxes | −62,827 | $78.37 | $4.9M | 127,358 |
| 2025-12-09 | SWAFFORD CHARLOTTE A Director | Option exercise · Stock Options (Right to Buy) 2-25-2021 | −25,000 | 0 | ||
| 2025-12-09 | SWAFFORD CHARLOTTE A Director | Option exercise · Stock Option (Right to buy) 2022 | −25,000 | 0 | ||
| 2025-12-09 | SWAFFORD CHARLOTTE A Director | Option exercise · Stock Option (Right to Buy) 2023 | −10,000 | 0 |
Page 6 of 17 · 332 trades